Works matching IS 14642662 AND DT 2016 AND VI 17 AND IP 2

Results: 10

The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 106, doi. 10.1111/hiv.12281

By:

Wohl, DA;
Bhatti, L;
Small, CB;
Edelstein, H;
Zhao, HH;
Margolis, DA;
DeJesus, E;
Weinberg, WG;
Ross, LL;
Shaefer, MS

Publication type:

Article

Table of Contents.

Published in:: HIV Medicine, 2016, v. 17, n. 2, p. 79, doi. 10.1111/hiv.12326
Publication type:: Article

HIV and new onset seizures: slipping through the cracks in HIV care and treatment.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 118, doi. 10.1111/hiv.12283

By:

Sikazwe, I;
Elafros, MA;
Bositis, CM;
Siddiqi, OK;
Koralnik, IJ;
Kalungwana, L;
Theodore, WH;
Okulicz, JF;
Potchen, MJ;
Birbeck, GL

Publication type:

Article

Healthcare providers' knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 133, doi. 10.1111/hiv.12285

By:

Desai, M;
Gafos, M;
Dolling, D;
McCormack, S;
Nardone, A

Publication type:

Article

Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal ( Actuel sur Rue).

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 152, doi. 10.1111/hiv.12286

By:

Lebouché, B;
Engler, K;
Machouf, N;
Lessard, D;
Thomas, R

Publication type:

Article

HIV encephalopathy: glial activation and hippocampal neuronal apoptosis, but limited neural repair.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 143, doi. 10.1111/hiv.12288

By:

Tauber, SC;
Staszewski, O;
Prinz, M;
Weis, J;
Nolte, K;
Bunkowski, S;
Brück, W;
Nau, R

Publication type:

Article

Essentials from the 2015 European AIDS Clinical Society ( EACS) guidelines for the treatment of adult HIV-positive persons.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 83, doi. 10.1111/hiv.12322

By:

Ryom, L;
Boesecke, C;
Gisler, V;
Manzardo, C;
Rockstroh, JK;
Puoti, M;
Furrer, H;
Miro, JM;
Gatell, JM;
Pozniak, A;
Behrens, G;
Battegay, M;
Lundgren, JD

Publication type:

Article

A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 124, doi. 10.1111/hiv.12284

By:

O'Connor, JL;
Gardner, EM;
Esser, S;
Mannheimer, SB;
Lifson, AR;
Telzak, EE;
Phillips, AN

Publication type:

Article

Editorial Board.

Published in:: HIV Medicine, 2016, v. 17, n. 2, p. 77, doi. 10.1111/hiv.12327
Publication type:: Article

Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.

Published in:

HIV Medicine, 2016, v. 17, n. 2, p. 89, doi. 10.1111/hiv.12310

By:

Younas, M;
Psomas, C;
Reynes, J;
Corbeau, P

Publication type:

Article